Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

49.08 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,528
Open 49.08
Bid (Size) 49.19 (100)
Ask (Size) 49.48 (400)
Prev. Close 49.08
Today's Range 49.08 - 49.08
52wk Range 42.52 - 63.30
Shares Outstanding 2,222,113,553
Dividend Yield 5.05%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Healthcare Stocks Topping a 2025 List of Dividend Yields ↗
Turn health into wealth with these three high-yielding dividend stocks. 
Via The Motley Fool
News headline image
Jim Cramer Is Backing Off Bristol-Myers, But These 2 Chinese Stocks Are Good ↗
"Mad Money" host Jim Cramer discusses Bristol-Myers Squibb, Baidu, Alibaba, Brinker and New Era Energy & Digital. 
Via Benzinga

Performance

YTD
-13.6%
-13.6%
1 Month
+12.7%
+12.7%
3 Month
+2.6%
+2.6%
6 Month
+11.2%
+11.2%
1 Year
-16.8%
-16.8%

More News

Read More
News headline image
Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern
Via MarketMinute
BMY CEO Expects Cancer Drug Opdivo To Drive Strong Sales In 2025 ↗
Via Stocktwits
News headline image
Earnings Scheduled For October 30, 2025 ↗
Via Benzinga
News headline image
Cliff Asness: The Stock Market is Expensive, Not a Bubble – A Call for Rationality in a Less Efficient Market
Via MarketMinute
Topics Economy
News headline image
Bristol Myers Squibb Prices €5 Billion of Senior Unsecured Notes
From Bristol Myers Squibb
Via Business Wire
News headline image
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership ↗
Via Benzinga
News headline image
Cleveland-Cliffs, Meta And Rocket On CNBC's 'Final Trades' ↗
Via Benzinga
News headline image
Bristol Myers Squibb Co (NYSE:BMY) Presents a Compelling Value Investment Case ↗
Via Chartmill
Topics Intellectual Property
News headline image
Bristol Myers Squibb Showcases New Long-Term and Real-World Data From Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2025
From Bristol Myers Squibb
Via Business Wire
News headline image
Bristol Myers Squibb Announces Cash Tender Offers to Purchase Certain Notes
From Bristol Myers Squibb
Via Business Wire
News headline image
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Via MarketMinute
Topics Intellectual Property
News headline image
Bristol-Myers Squibb Co (NYSE:BMY) Offers a Compelling Mix of High Yield and Dividend Growth ↗
Via Chartmill
News headline image
Discover which S&P500 stocks are making waves on Thursday. ↗
Via Chartmill
News headline image
Bristol-Myers Squibb (BMY) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Bristol Myers' New Treatments Drive Q3 Beat — And The Company's Raising Its Outlook ↗
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
Bristol-Myers Squibb (NYSE:BMY) Reports Bullish Q3
Via StockStory
News headline image
Bristol Myers Squibb Co (NYSE:BMY) Q3 2025 Earnings Beat Estimates ↗
Via Chartmill
Topics Earnings
News headline image
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday? ↗
Via Benzinga
Topics Economy
News headline image
Bristol Myers Squibb Reports Third Quarter Financial Results for 2025
From Bristol Myers Squibb
Via Business Wire
News headline image
What to Expect from Bristol-Myers Squibb's Earnings ↗
Via Benzinga

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 49.08
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 11/12/25 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 109.06B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 109B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.